Sector Investment 3 Days

Last updated: May 12, 2026, 11:30 PM ET

Real Estate Fundraising & Strategy Shifts

Major players in real estate investment are aggressively pursuing new capital pools and recalibrating mandates across Europe and Asia, signaling a divergence in strategy between core and opportunistic mandates. BNP Paribas Asset Management Alternatives successfully amassed €3bn for a European credit strategy focused on lending against transitional real estate, aiming for high single-digit internal rates of return. Concurrently, AEW Europe, under new CEO Vanessa Roux-Collet, is actively planning to diversify its product range beyond traditional core and core-plus offerings to capture broader market segments. In parallel, Digital Realty, the world’s largest data center REIT by footprint, is charting a substantial private fundraising push, targeting a cornerstone raise of up to $3bn for a new US open-end fund, indicating platform expansion even as public markets remain volatile.

The push for transaction volume remains high, particularly for opportunistic bets, with Brookfield expecting to execute $20bn worth of real estate transactions over the next two months, driven by what its president termed a "very rapid acceleration" in recovery. This deal momentum is mirrored in specialist sectors; Newcore secured approximately £100m in equity commitments for the first close of its sixth social infrastructure fund focused on the UK market. Meanwhile, Japanese buyout specialist Advantage Partners is leveraging its recent expansion into real estate to help double its assets under management, concentrating on corporate-owned properties.

Sector-Specific Investments & Regulatory Tailwinds

Specific asset classes are seeing targeted capital deployment, with hospitality undergoing strategic repositioning in Australia. Pro-invest acquired the A$100m Coogee Sands Hotel & Apartments in Sydney as the initial step in a strategy to convert hospitality assets into alternative temporary accommodation formats. Regulatory shifts in Australia may further unlock capital for housing strategies, as reforms under consideration could introduce an ‘emerging covered asset class’ to encourage more investment into affordable housing. Separately, in healthcare, investment focus remains tightly coupled with high-cost treatment areas, as oncology accounts for roughly 40% of national drug spend, closely followed by retina treatments, suggesting distributors are building ecosystems around these high-value pharmaceutical segments.